Table 1.
Characteristics of 557 mantle cell lymphoma cases and 13766 controls included in the InterLymph NHL Subtypes Project
| Controls, No. (%) | Cases, No. (%) | |
|---|---|---|
| Total | 13766 (96.1) | 557 (3.9) |
| Age, y | ||
| <30 | 769 (5.6) | 1 (0.2) |
| 30–39 | 1133 (8.2) | 14 (2.5) |
| 40–49 | 1974 (14.3) | 44 (7.9) |
| 50–59 | 3323 (24.1) | 163 (29.3) |
| 60–69 | 3835 (27.9) | 203 (36.4) |
| 70–79 | 2474 (18.0) | 118 (21.2) |
| ≥80 | 258 (1.9) | 11 (2.0) |
| Missing | 0 (0.0) | 3 (0.5) |
| Sex | ||
| Male | 7206 (52.3) | 412 (74.0) |
| Female | 6560 (47.7) | 145 (26.0) |
| Race/ethnicity | ||
| White, non-Hispanic | 12854 (93.4) | 523 (93.9) |
| Black | 199 (1.4) | 3 (0.5) |
| Asian | 189 (1.4) | 10 (1.8) |
| Hispanic | 121 (0.9) | 6 (1.1) |
| Other/unknown/missing | 403 (2.9) | 15 (2.7) |
| Socioeconomic status | ||
| Low | 4771 (34.7) | 208 (37.3) |
| Medium | 4532 (32.9) | 168 (30.2) |
| High | 4216 (30.6) | 166 (29.8) |
| Other/missing | 247 (1.8) | 15 (2.7) |
| Region | ||
| North America | 5060 (36.8) | 253 (45.4) |
| Northern Europe* | 6542 (47.5) | 264 (47.4) |
| Southern Europe† | 1470 (10.7) | 18 (3.2) |
| Australia | 694 (5.0) | 22 (3.9) |
| Design | ||
| Population-based | 9673 (70.3) | 435 (78.1) |
| Hospital-based | 4093 (29.7) | 122 (21.9) |
| Lymphoma stage at diagnosis | ||
| N/A (Controls) | 23096 (100.0) | 0 (0.0) |
| Stages I–II | — | 62 (11.1) |
| Stages III–IV | — | 351 (63.2) |
| Unknown/unclassifiable | — | 143 (25.7) |
* Includes Sweden, Denmark, Germany, United Kingdom, Ireland, France, and Czech Republic.
† Includes Spain and Italy.